Sleep, Stress and Migraine - an Observational and Training Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSusanne Wegener
About this trial
The MiSleepS study investigates how sleep disturbances and stress are linked to migraine attacks. Participants wear a device called a WHOOP band, which tracks sleep and body signals, and answer brief daily questions via a smartphone app about their sleep, stress levels, and migraine symptoms. The goal is to identify personal patterns that may contribute to migraine. Based on these insights, participants receive individualized recommendations to improve their sleep and daily routines - aiming to reduce migraine attacks in the long term without medication. The study is conducted at the University Hospital Zurich and is aimed at adults with episodic migraine.
Eligibility criteria
Qualifiers
Adults aged between 18 and 65 years
Diagnosis of episodic migraine according to The International Classification of Headache Disorders (ICHD-3) criteria confirmed by our headache specialists
4 to 14 headache days per month (mean value based on the 3 months prior to study enrollment)
Ability to give informed consent and to adhere to the study protocol
Disqualifiers
Diagnosis of sleep disorders that could interfere with the sleep intervention, such as obstructive sleep apnea with an apnea-hypopnea index (AHI) > 15, Restless Legs Syndrome, frequent (i.e. weekly) Non-rapid eye movement (NREM) sleep parasomnia, REM Behavior Disorder (RBD)
Current diagnosis of a psychiatric disorder that is inadequately treated or therapy-resistant and may interfere with study participation or adherence to study procedures (this includes, but is not limited to: schizophrenia, schizoaffective disorder, bipolar disorder (type I), post-traumatic stress disorder with active symptoms, or major depressive disorder with ongoing functional impairment despite treatment). Diagnosis must be confirmed by clinical history or treating physician.
Regular use of benzodiazepines and other central nervous system (CNS)-depressant substances (self-reported)
Concomitant steroid medication (self-reported)
Trial design
Treatments tested in this trial
- Profile-based behavioral sleep and stress management
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Susanne Wegener
Lead sponsor
University of Zurich
Sponsor institution
Source ClinicalTrials.gov